company background image
CYAN

CyanotechNasdaqCM:CYAN Stock Report

Market Cap

US$22.0m

7D

14.5%

1Y

27.6%

Updated

30 Nov, 2021

Data

Company Financials
CYAN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

CYAN Stock Overview

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide.

Cyanotech Competitors

DIC

TSE:4631

JP¥272.3b

Price History & Performance

Summary of all time highs, changes and price drops for Cyanotech
Historical stock prices
Current Share PriceUS$3.55
52 Week HighUS$6.29
52 Week LowUS$2.61
Beta0.28
1 Month Change15.63%
3 Month Change12.34%
1 Year Change27.61%
3 Year Change-4.05%
5 Year Change-1.49%
Change since IPO255.00%

Recent News & Updates

Nov 30
Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital

Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Jun 08
Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt

Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

CYANUS Personal ProductsUS Market
7D14.5%-4.1%-2.8%
1Y27.6%20.9%20.0%

Return vs Industry: CYAN exceeded the US Personal Products industry which returned 20.9% over the past year.

Return vs Market: CYAN exceeded the US Market which returned 20% over the past year.

Price Volatility

Is CYAN's price volatile compared to industry and market?
CYAN volatility
CYAN Average Weekly Movement4.8%
Personal Products Industry Average Movement9.4%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: CYAN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: CYAN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198396Gerry Cysewskihttps://www.cyanotech.com

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant that is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors.

Cyanotech Fundamentals Summary

How do Cyanotech's earnings and revenue compare to its market cap?
CYAN fundamental statistics
Market CapUS$21.99m
Earnings (TTM)US$2.12m
Revenue (TTM)US$34.81m

10.4x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CYAN income statement (TTM)
RevenueUS$34.81m
Cost of RevenueUS$22.42m
Gross ProfitUS$12.39m
ExpensesUS$10.27m
EarningsUS$2.12m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.34
Gross Margin35.58%
Net Profit Margin6.09%
Debt/Equity Ratio29.8%

How did CYAN perform over the long term?

See historical performance and comparison

Valuation

Is Cyanotech undervalued compared to its fair value and its price relative to the market?

10.38x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CYAN ($3.55) is trading above our estimate of fair value ($0.65)

Significantly Below Fair Value: CYAN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CYAN is good value based on its PE Ratio (10.4x) compared to the US Personal Products industry average (16.7x).

PE vs Market: CYAN is good value based on its PE Ratio (10.4x) compared to the US market (16.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CYAN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CYAN is good value based on its PB Ratio (1.2x) compared to the US Personal Products industry average (3x).


Future Growth

How is Cyanotech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.2%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cyanotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Cyanotech performed over the past 5 years?

44.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CYAN has a large one-off gain of $1.3M impacting its September 30 2021 financial results.

Growing Profit Margin: CYAN's current net profit margins (6.1%) are higher than last year (1.8%).


Past Earnings Growth Analysis

Earnings Trend: CYAN has become profitable over the past 5 years, growing earnings by 44.6% per year.

Accelerating Growth: CYAN's earnings growth over the past year (262.1%) exceeds its 5-year average (44.6% per year).

Earnings vs Industry: CYAN earnings growth over the past year (262.1%) exceeded the Personal Products industry 60.8%.


Return on Equity

High ROE: CYAN's Return on Equity (11.4%) is considered low.


Financial Health

How is Cyanotech's financial position?


Financial Position Analysis

Short Term Liabilities: CYAN's short term assets ($15.4M) exceed its short term liabilities ($4.6M).

Long Term Liabilities: CYAN's short term assets ($15.4M) exceed its long term liabilities ($7.6M).


Debt to Equity History and Analysis

Debt Level: CYAN's net debt to equity ratio (18.3%) is considered satisfactory.

Reducing Debt: CYAN's debt to equity ratio has reduced from 44.9% to 29.8% over the past 5 years.

Debt Coverage: CYAN's debt is well covered by operating cash flow (30.4%).

Interest Coverage: CYAN's interest payments on its debt are not well covered by EBIT (2.7x coverage).


Balance Sheet


Dividend

What is Cyanotech current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CYAN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CYAN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CYAN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CYAN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CYAN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Gerry Cysewski (72 yo)

2.5yrs

Tenure

US$124,009

Compensation

Dr. Gerald R. Cysewski, also known as Gerry, Ph D., Co-Founded Cyanotech Corp. in 1983 and has been its Director since 1983. He serves as Vice Chairman at Cyanotech Corporation and serves as its Chief Exec...


CEO Compensation Analysis

Compensation vs Market: Gerry's total compensation ($USD124.01K) is below average for companies of similar size in the US market ($USD563.50K).

Compensation vs Earnings: Gerry's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CYAN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: CYAN's board of directors are considered experienced (6.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cyanotech Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Cyanotech Corporation
  • Ticker: CYAN
  • Exchange: NasdaqCM
  • Founded: 1983
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$21.989m
  • Shares outstanding: 6.19m
  • Website: https://www.cyanotech.com

Number of Employees


Location

  • Cyanotech Corporation
  • 73-4460 Queen Kaahumanu Highway
  • Suite 102
  • Kailua-Kona
  • Hawaii
  • 96740
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/30 23:56
End of Day Share Price2021/11/30 00:00
Earnings2021/09/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.